Log in
Enquire now
‌

US Patent 9921218 Signal amplification in lateral flow and related immunoassays

Patent 9921218 was granted and assigned to Abaxis on March, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Abaxis
Abaxis
0
Current Assignee
Abaxis
Abaxis
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
99212180
Patent Inventor Names
Jeremy Walker0
Rajesh K. Mehra0
Cristina Cuesico0
Dennis M. Bleile0
Kenneth P. Aron0
Date of Patent
March 20, 2018
0
Patent Application Number
146884190
Date Filed
April 16, 2015
0
Patent Citations Received
‌
US Patent 11977072 Solution-based plasmonic specific-binding partner assays using metallic nanostructures
0
Patent Primary Examiner
‌
Gailene Gabel
0
Patent abstract

The present invention provides methods, devices, compositions (e.g., capture complexes), and kits useful for enhancing the detection of antibodies in a test sample. The methods, devices, and compositions utilize detectable Fc-binding molecules such as Protein A, Protein G, and/or an Fc-specific antibody to amplify the signal of a detected antibody in immunoassays, such as lateral flow assays.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9921218 Signal amplification in lateral flow and related immunoassays

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.